Euglena Balance Sheet Health
Financial Health criteria checks 4/6
Euglena has a total shareholder equity of ¥31.3B and total debt of ¥26.9B, which brings its debt-to-equity ratio to 85.8%. Its total assets and total liabilities are ¥70.3B and ¥39.0B respectively.
Key information
85.8%
Debt to equity ratio
JP¥26.89b
Debt
| Interest coverage ratio | n/a |
| Cash | JP¥19.09b |
| Equity | JP¥31.33b |
| Total liabilities | JP¥38.96b |
| Total assets | JP¥70.28b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 2931's short term assets (¥29.2B) exceed its short term liabilities (¥12.3B).
Long Term Liabilities: 2931's short term assets (¥29.2B) exceed its long term liabilities (¥26.7B).
Debt to Equity History and Analysis
Debt Level: 2931's net debt to equity ratio (24.9%) is considered satisfactory.
Reducing Debt: 2931's debt to equity ratio has increased from 27% to 85.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 2931 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 2931 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.